Register now!Newsletter subscription

  • CATALOG PDF Download
  • BROCHURES PDF Download

Anti-Influenza A Virus Nucleoprotein


Influenza virus is an RNA virus, which causes influenza, and belongs to the family Orthomyxoviridae. Influenza virus is classified into three different genera, influenzavirus A, B, and C. They all have similar structures and compositions. The virions are 80-100nm in diameter and usually roughly spherical. The outer surface of the virion is made of a viral envelope containing two major glycoproteins, hemagglutinin (HA) and neuraminidase (NA). Influenzavirus A is further classified into subtypes based on the surface glycoproteins, HA and NA. Currently, there are 16 HA and 9 NA subtypes. The central core of the virion contains the viral RNA genome, which is packaged in the form of ribonucleoprotein complexes. Influenza virus nucleoprotein (NP) is a major component of the ribonucleoprotein complex and is abundantly expressed during the course of infection. It is a structural protein, which encapsidates the negative strand viral RNA and is essential for RNA transcription, replication and packaging. NP binds the PB1 and PB2 subunits of the viral RNA polymerase and the matrix protein M1, in addition to its binding to ssRNA. NP is also known to interact with variety of other macromolecules of both viral and cellular origins, and these interactions have been shown to be essential for the viral lifecycle.



Figure. Western blotting of MDCK cells infected with H1N1 (A/PuertoRico/8/34), H5N1 (A/duck/HK/342/78), or H5N2 (A/crow/Kyoto/53/04) using C43 antibody. Samples were collected at 3, 9, 24, and 48 hours post-infection. C43 detected NP after 3 hours post-infection and detected three different types of influenza viruses.


Product List

Product Name Cat# Quantity Price

Anti Influenza A Virus Nucleoprotein

BAM-65-111EX 50UG

¥ 34,500
$ 460
€ 345

  •  Mizuike R. et al. Development of Two Types of Rapid Diagnostic Test Kits To Detect the Hemagglutinin or Nucleoprotein of the Swine-Origin Pandemic Influenza A Virus H1N1. Clin Vaccine Immunol 18: 494-499 (2011)PMID: 21228147 (IF/IHC)
  • Ueda M. et al. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus. Virus Research 136: 91-97 (2008).PMID: 18550190 (WB)
  • Okuno Y et al . A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552?2558 (1993) PubMed ID:7682624PMID: 21228147 (IF/IHC)

To be used for research only. DO NOT use for human gene therapy or clinical diagnosis.